FDA Inspection 1161247 — Losan Pharma GmbH

Losan Pharma GmbH — FEI 3004174480

The FDA completed an inspection of Losan Pharma GmbH on Apr 15, 2021 in Neuenburg Am Rhein. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 15, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Neuenburg Am Rhein (Germany)

Additional details

Mutual Recognition Agreement (MRA)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.